RING E3 ligases catalyze the transfer of ubiquitin (Ub) from E2 ubiquitin-conjugating enzyme thioesterified with Ub (E2~Ub) to substrate. For RING E3 dimers, the RING domain of one subunit and tail of the second cooperate to prime Ub, but how this is accomplished by monomeric RING E3s in the absence of a tail-like component is currently unknown. Here, we present a crystal structure of a monomeric RING E3, Tyr363-phosphorylated human CBL-B, bound to a stabilized Ub-linked E2, revealing a similar mechanism in activating E2~Ub. Both pTyr363 and the pTyr363-induced element interact directly with Ub's Ile36 surface, improving the catalytic efficiency of Ub transfer by ~200-fold. Hence, interactions outside the canonical RING domain are crucial for optimizing Ub transfer in both monomeric and dimeric RING E3s. We propose that an additional non-RING Ub-priming element may be a common RING E3 feature. npg
a r t i c l e s Post-translational modification by Ub regulates protein functions by altering their stability, activity, localization and protein-protein interaction network and is therefore essential for diverse biological processes. Ub conjugation requires the consecutive actions of three classes of enzymes: Ub-activating enzyme (E1), E2 and E3 (ref. 1) . Initially, an E1 activates and transfers Ub to an E2, and a covalent thioester is formed between E2's catalytic cysteine and the C-terminal glycine on the tail of Ub. Subsequently, an E3 recruits substrate and E2~Ub to catalyze the formation of an isopeptide bond between the C-terminal glycine of Ub and an amino group of a lysine side chain on a protein substrate. E3s confer specificity to ubiquitination by promoting Ub transfer to select substrates; defects in E3 function are associated with many major disease pathologies including cancer, neurodegenerative disorders and metabolic disease 2, 3 .
Over 600 E3s have been identified in mammals, and most belong to the RING family of E3 ligases (reviewed in refs. 4, 5) . RING E3s act as scaffolds, simultaneously recruiting both substrate and E2~Ub through different domains to promote Ub transfer in the absence of a covalent E3-Ub intermediate. The RING-finger domain is essential for the recruitment of E2~Ub and comprises a defined motif of cysteine and histidine residues that bind two zinc ions in a 'crossbrace' arrangement. Several types of RING E3s have been recognized and classified according to the oligomeric state required for function. Regardless of type, the RING-E2 interface is always distal to the E2 active site in RING E3-E2 complex structures [6] [7] [8] [9] , and biochemical and recent structural studies suggest that all types promote Ub transfer through an allosteric mechanism in which multiple interactions between the E3, E2 and Ub lock the conformation of the tail of Ub, thereby activating the thioester bond for nucleophilic attack [10] [11] [12] [13] . E2-mediated interactions with the Ile44 surface of Ub are an essential component of this mechanism 14, 15 , and for dimeric RING E3s, recent structural studies of RING-E2-Ub complexes have shown that E3-mediated interactions with the Ile36 surface of Ub are also crucial 12, 13 . These Ile36 surface interactions are facilitated by a crossdimer arrangement in which one subunit of the RING dimer binds E2 and Ub's Ile36 surface, and the tail of the second subunit also binds this Ub surface. Both RING-and dimer tail-mediated interactions with Ub are required for optimal Ub transfer. In monomeric RING E3s, the RING domain can mediate interactions with the Ile36 surface of Ub, but whether this is sufficient for optimal Ub transfer or requires an additional Ub-interacting structural component such as the tail in RING E3 dimers is unclear.
The monomeric family of CBL RING E3 ligases (c-CBL, CBL-B and CBL-C) attenuate nonreceptor and receptor tyrosine kinase (RTK) signaling by ubiquitinating and thereby directing these kinases for degradation through the endocytic or proteasomal pathway (reviewed in ref. 16 ). Members of the CBL family share a highly conserved N terminus comprising a tyrosine kinase-binding domain (TKBD), a linker helix region (LHR) and a RING domain (~435 amino acids). The C terminus is more variable, comprising a proline-rich region and an extension. The TKBD contains a phosphotyrosine-recognition motif that functions as a substrate-binding site, in which phosphorylated RTKs and non-RTKs such as epidermal growth factor receptor and ZAP-70, respectively, are recruited for ubiquitination [17] [18] [19] . Phosphorylation of a strictly conserved tyrosine within the LHR (Tyr363 in CBL-B, Tyr371 in c-CBL and Tyr341 in CBL-C) enhances ligase activity and is required for CBL-mediated ubiquitination of RTKs 17, 20, 21 . To investigate how monomeric RING E3s promote Ub transfer, we used CBL as a model system and determined the structure of a fragment of phosphorylated Tyr363 (pTyr363)-CBL-B encompassing the TKBD, LHR and RING domain (residues 36-427, hereby referred to as CBL-B, Fig. 1a ) bound to a ZAP-70 substrate peptide and a r t i c l e s the E2 UbcH5B linked to Ub by an isopeptide bond (UbcH5B-Ub). E3 binding promotes numerous Ub contacts required to lock the position of Ub's tail for transfer and activate the E2~Ub thioester. The RING-Ub and E2-Ub interactions are almost identical to those observed in the dimeric RING E3-E2-Ub complexes. Notably, pTyr363 directly contacts Ub's Ile36 surface in a manner similar to that of the tail of the RING dimers. Although previous studies have shown that phosphorylation of this LHR tyrosine activates the ligase by inducing conformational changes that eliminate autoinhibition and bridge the gap between the RING domain and substrate-binding site 22, 23 , this structure and accompanying biochemical and NMR data demonstrate that the phosphorylation-induced structural element is also required for positioning Ub for catalysis. We propose that monomeric RING E3s require an additional non-RING component to mediate Ub interactions for optimal activity. This is, to our knowledge, the first structure-based elucidation of the mechanism of monomeric RING-mediated Ub transfer.
RESULTS

Structure of pCBL-B-E2-Ub-ZAP-70 peptide complex
We made several protein modifications to generate suitable UbcH5B-Ub and pTyr363-CBL-B for structural and biochemical studies. We mutated UbcH5B's Cys85 to lysine to form an isopeptide bond with the terminal glycine of Ub and Ser22 to arginine to prevent backside binding with Ub 12, 24 . In CBL-B, both Tyr360 and Tyr363 (the phosphorylation activation site) are located on the linker helix and are accessible for modification, so we mutated Tyr360 to phenylalanine to generate homogeneously Tyr363-phosphorylated CBL-B (hereby referred to as pCBL-B). Neither the activity nor the structure is affected when the equivalent site is mutated (Y368F) in Tyr371phosphorylated c-CBL 22 , and, in comparison to the previously elucidated solution-based structure of the LHR and RING domain of wild-type pTyr363-CBL-B 23 , no considerable differences are evident in the corresponding region of our pCBL-B structure (r.m.s. deviation 1.52 Å for Cα atoms of residues 353-426).
To investigate the mechanism of monomeric RING E3-mediated Ub transfer, we determined the structure of pCBL-B bound to UbcH5B-Ub and a ZAP-70 substrate peptide ( Fig. 1 and Table 1 ). The peptide comprises the amino acid sequence from ZAP-70 (residues 286-297) recognized by the phosphotyrosine-binding motif of CBL-B and c-CBL but contains no lysines and thus cannot function as a substrate. The heterotrimeric protein-peptide complex crystallized in space group P12 1 1, and there are four copies in the asymmetric unit (r.m.s. deviation 0.41-0.57 Å for Cα atoms); our analysis focuses on the subunit comprising chains E-H, which had the best quality of density at the Ub-RING interface. The structures of the individual protein domains are similar to those of the models used for molecular replacement (Online Methods), and the substrate-peptide binding mode is comparable to that of other CBL TKBD-peptide complexes 25, 26 .
pCBL-B adopts an active configuration in which pTyr363 directly contacts the RING domain, thereby placing the linker helix adjacent to the RING domain and extending the E2-binding surface, as observed previously 23 (Fig. 1b) . The RING domain contacts the substrate-binding face of the TKBD and orients the UbcH5B-Ub linkage toward the substrate-binding site. This pCBL-B-E2-ZAP-70 peptide conformation is nearly identical to the one observed in the complex structure of Tyr371-phosphorylated c-CBL bound to UbcH5B and ZAP-70 peptide 22 Supplementary Fig. 1a-c) . Despite the presence of Ub in the pCBL-B complex, the UbcH5B-RING interactions are comparable in the two phosphorylated CBL complexes and resemble other E2-RING interfaces 6, 7 .
pTyr363 directly contacts Ub pCBL-B's pTyr363 directly interacts with Ub's Ile36 surface ( Fig. 1c and  Supplementary Fig. 1d ). The side chain of Ub's Thr9 forms a hydrogen bond with the phosphate moiety from pCBL-B's pTyr363, and Ub's Lys11 forms hydrophobic interactions with pCBL-B's Leu362, pTyr363 and Met366. As with the deubiquitinating enzyme DUBA, the single phosphate seems to precisely position Ub for catalysis 27 . To investigate whether this pTyr363-Ub interaction affects enzymatic activity, we compared Ub transfer mediated by unphosphorylated and phosphorylated CBL-B. Phosphorylation of CBL's linker helix contributes to enzyme activity enhancement by abolishing RING-TKBD-mediated autoinhibition and by positioning the RING domain adjacent to the substrate-binding site on the TKBD 22, 23 ; to eliminate these contributions so that the effect of pTyr363 on E2~Ub transfer could be assessed, we used a fragment of CBL-B comprising only the LHR and RING domain (CBL-B LRR , residues 346-427). This fragment lacks the TKBD and therefore cannot adopt an autoinhibited conformation but is defective in both auto-and substrate-ubiquitination assays; hence, we investigated Ub transfer, using single-turnover lysine-discharge assays. Notably, pCBL-B LRR promoted discharge more quickly than did the corresponding unphosphorylated fragment ( Fig. 2a) .
Furthermore, to determine whether pTyr363 contacts Ub in solution, we performed 31 P-NMR on pCBL-B LRR with several UbcH5B-Ub variants under saturating conditions. Given that there is only one phosphate group in pCBL-B LRR , the chemical shift observed corresponds to the phosphate environment of pTyr363. Addition of UbcH5B alone induced a small chemical shift in pTyr363 (∆ 0.02 p.p.m.). This shift substantially increased (∆ 0.58 p.p.m.) when Ub was linked to UbcH5B (Fig. 2b-d) . Furthermore, when Ub's Thr9 or Lys11 was mutated to alanine, the effects of adding UbcH5B-Ub diminished, more so for Ub T9A than K11A ( Fig. 2e,f) . These data are consistent with our structural observations.
pTyr363-induced structural element is required for activity
Ub appears poised for transfer in the complex. In addition to the Ub-linker helix interactions, extensive contacts between Ub's Ile36 surface and pCBL-B's RING domain, Ub's Ile44 surface and UbcH5B's α3, and Ub's tail and UbcH5B's α2 along with residues 112-117 ( Supplementary Fig. 2a-c Fig. 2d ). For the dimeric RING E3s, multiple interactions between the RING, E2 and Ub lock the tail of Ub into a conformation in which the thioester is optimally oriented for nucleophilic attack 12 ; activating the thioester not only requires these Ub-E2 and Ub-RING interactions but also depends on Ub interactions with the tail of the second dimer 12, 13, 28, 29 . Notably, the phosphorylated linker helix in pCBL-B seemingly replaces the dimer tail in BIRC7 and RNF4-both structural elements contact the Ile36 surface of Ub, though the interaction is predominantly mediated by an aromatic residue in the dimer and the phosphate moiety in pCBL-B (Fig. 1c,d) . 
a r t i c l e s
The parallels between pCBL-B and these two dimeric RING E3s suggest that they use similar mechanisms to promote Ub transfer. To investigate pCBL-B's mechanism, we mutated key residues in the Ub-UbcH5B and Ub-pCBL-B interfaces and tested them in singleturnover lysine-discharge assays. All of these mutants were defective in Ub transfer, including those in the pTyr363-linker helix-Ub interface, and thus the observed Ub interactions are crucial for Ub transfer (Supplementary Fig. 2e-g) . For the dimeric RING E3s, mutations within any of the Ub-E2 or Ub-E3 interfaces increase K m and decrease k cat in steady-state analyses because stabilization of Ub is a key requirement for optimization of the conformation of the E2~Ub thioester bond for transfer 13 . We postulate that if the dimer tail and pTyr363-linker helix have similar functions, then removing the phosphate, perturbing the phosphate-binding site or disrupting the pTyr363-Ub interface will likewise affect both K m and k cat . We tested these three hypotheses, using CBL-B LRR , pCBL-B LRR K381A and Ub T9A, respectively, in di-Ub formation assays and found that, indeed, all three variants detrimentally affected K m and k cat as compared to the reaction with pCBL-B LRR and wild-type Ub ( Fig. 3 and  Supplementary Fig. 3) . Together, our structural and biochemical data demonstrate that the monomeric RING E3 pCBL-B uses an Ub-tail locking mechanism to promote Ub transfer, like the RING E3 dimers BIRC7 and RNF4.
DISCUSSION
Our present work provides the first structural evidence elucidating the mechanism of Ub transfer by a monomeric RING E3. Like other RING and U-box E3s, CBL-B uses an allosteric mechanism in which E3-E2, E3-Ub and E2-Ub interactions restrain Ub into a closed, 'folded-back' conformation and position Ub's tail for transfer [10] [11] [12] [13] [14] [15] .
Here, we show that CBL-B positions Ub's C-terminal tail along UbcH5B's active site cleft in the same manner as do the dimeric RING E3s BIRC7 and RNF4 (refs. 12,13) and mirrors SUMO's C-terminal tail, as observed in the complex structure of the non-RING E3 RanBP2 bound to Ubc9 and SUMO-modified substrate 30 . UbcH5B's α2 residues and the loop encompassing residues 112-117 cooperate to lock Ub's tail into a conformation that activates the E2~Ub thioester; UbcH5B's Asn77 stabilizes Ub's Gly76 carbonyl oxygen through a hydrogen bond, and UbcH5B's Asp117 is poised to activate the incoming lysine, as described previously 12, 31 (Supplementary Fig. 2b) .
It is noteworthy that stabilization of the globular Ub body is a critical component for optimal positioning of Ub's tail and hence Ub transfer 12, 13 . This is mediated by direct interactions between the E3 and Ub's Ile36 surface and between Ub's Ile44 surface and UbcH5B's α3. CBL-B adopts a strategy similar to that of the dimeric RING E3s BIRC7 and RNF4 in stabilizing the Ile36 surface of Ub. Two E3 components mediate this stabilizing interaction: the RING itself and an additional structural element outside the canonical RING domain (Figs. 1c,d and 4a,b) . In the RING E3 dimers, the tail acts as this additional Ub-binding component, and in CBL-B, phosphorylation of Tyr363 generates a structural element adjacent to the RING domain that functionally mimics the dimer tail and enhances catalytic efficiency by ~200-fold ( Fig. 3) . We postulate that optimal enzymatic activity is essential in cells, in which ubiquitination is highly dynamic and requires efficiency. Indeed, mutations that disrupt the linkerhelix pTyr-binding interface in c-CBL reduce catalytic efficiency and compromise ubiquitination of epidermal growth factor receptor in cells 22 . Likewise, dimeric RING E3 tail mutations hamper substrate ubiquitination in cells 8, 32, 33 .
A similar allosteric Ub-priming mechanism is used to promote transfer in SUMO E3 ligases 30, 34 . For the SUMO RING E3 Siz1, modeling and biochemical assays suggest that an acidic patch on an α-helix outside of the RING domain directly contacts the conserved basic patch on the backside of SUMO to position E2~SUMO for transfer 34 (Supplementary Fig. 4) . Notably, this basic patch on SUMO does not correspond to Ub's Ile36 surface. Likewise, in the SUMO E3 RanBP2, SUMO is positioned for transfer by contacts with the E2-binding domain and an N-terminal extension that forms an antiparallel β-sheet with the adjacent SUMO surface, which is not the Ub Ile36 surface equivalent 30 (Supplementary Fig. 4) . Thus, additional Ub surfaces aside from Ile36 may be used to stabilize E3-mediated Ub transfer.
Our findings raise the question of whether other monomeric RING E3s require an additional Ub-binding element to stabilize Ub for transfer ( Fig. 4) . In all three RING E3-UbcH5-Ub complexes, the bulk of the RING-mediated Ub Ile36 surface interactions involve four highly conserved residues on the C-terminal Zn 2+ -binding loop of the RING domain ( Fig. 1c-e ). This Ub-binding RING quadrad is shared by several dimeric and monomeric RING E3s (Fig. 1e) . Given that this Ub-binding quadrad alone is not sufficient for optimal activity in CBL-B but depends upon a second non-RING Ub-binding element, npg it seems likely that other monomeric E3s with this RING motif will likewise require an additional Ub-binding component to stabilize Ub for transfer. Unfortunately, no such elements are readily identifiable in other monomeric RING E3s publicly available in the Protein Data Bank. Notably, in most cases, only the canonical RING domain of the E3 ligase has been structurally elucidated. Several monomeric RING and U-box E3s do not share this Ub-binding RING quadrad (Fig. 1e) . Two examples include RBX1, a RING-finger protein from a multisubunit Cullin-RING ligase (CRL) and the U-box E4B. The structures of full length Ufd2p (a yeast homolog of E4B) 35 and RBX1 in both unmodified and NEDD8-modified CRL complexes [36] [37] [38] do not reveal any obvious additional Ub-binding surface outside the canonical RING or U-box domain similar to pCBL-B's phosphorylated linker helix or the dimeric RING E3 tail. Despite this, RBX1 binds CDC34~Ub with ~50-fold-higher affinity than to unconjugated CDC34 (ref. 39) , and, in the case of E4B, weak U-box-Ub contacts are sufficient to drive E2~Ub toward a catalytically active closed conformation 11 . Variations in the Ub-E3 binding interface may preclude the necessity for additional Ub-binding components in these E3s. Alternatively, full-length protein may undergo conformational changes or require post-translational modifications to expose such an element. Likewise, another binding partner might assume this role. It is clear that further studies are required to investigate how other monomeric RING and U-box E3s optimize Ub for catalysis. Identification of additional Ub-binding elements, if present, may open new avenues for therapeutic targeting of RING or U-box E3s.
METHODS
Methods and any associated references are available in the online version of the paper. Accession code. Coordinates and structure factors for pCBL-B-UbcH5B-Ub-ZAP-70 peptide complex have been deposited in the Protein Data Bank under accession code 3ZNI.
